Trial Profile
Clinical study about the safety of Orexin receptor antagonist Suvorexant for severe sleep apnea syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2021
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 08 Dec 2021 Status changed from active, no longer recruiting to completed.
- 04 Jun 2021 Status changed from recruiting to active, no longer recruiting.
- 06 Jun 2017 New trial record